CommercialPrior AuthMedium impact
Levothyroxine Products (Revised)
Humana·Endocrinology, Family Medicine, Internal Medicine +1 more·Commercial
Effective date
Jan 1, 2024
We identified it
Jun 24, 2026
Summary
Humana has implemented a revised step therapy policy for levothyroxine products requiring members to try generic levothyroxine tablets before accessing brand-name alternatives like Tirosint, Tirosint-Sol, Unithroid, Ermeza, and Armour Thyroid. All covered brand-name thyroid medications now require prior authorization demonstrating previous treatment with generic levothyroxine tablet.
Action Required
Immediately: Billing team must obtain prior authorization for all brand-name levothyroxine products (Tirosint capsules, Tirosint-Sol oral solution, levothyroxine capsules, Unithroid tablets, Ermeza oral solution, and Armour Thyroid tablets) for Humana Commercial members. Providers must document previous treatment with generic levothyroxine tablets in prior authorization requests. Update encounter forms to remind providers of step therapy requirement. Claims for brand-name products without prior authorization will be denied.